Table 5.
Arterial and venous blood-gas responses at rest and with incremental exercise during normoxia and hypoxia in men and women
Normoxia |
Hypoxia |
|||||
---|---|---|---|---|---|---|
Rest | 10% | 20% | Rest | 10% | 20% | |
Young adults | ||||||
Men (n = 16) | ||||||
SaO2, % | 97 ± 0 | 97 ± 0 | 97 ± 0 | 81 ± 1* | 82 ± 1* | 82 ± 0* |
PaO2, Torr | 103 ± 2 | 104 ± 2 | 107 ± 2 | 46 ± 1* | 47 ± 1* | 48 ± 1* |
PvO2, Torr | 40 ± 3 | 28 ± 2† | 28 ± 1† | 29 ± 1* | 24 ± 1*† | 25 ± 1* |
Arterial O2 content, ml/1 | 189 ± 4 | 189 ± 5 | 190 ± 4 | 157 ± 4* | 161 ± 4* | 165 ± 5* |
Venous O2 content, ml/1 | 129 ± 8 | 85 ± 6† | 88 ± 5† | 95 ± 6* | 74 ± 6*† | 76 ± 7*† |
a-v O2, ml/1 | 61 ± 6 | 104 ± 6 | 102 ± 6 | 63 ± 5 | 87 ± 7* | 88 ± 6* |
O2 consumption, ml/min | 4.6 ± 0.7 | 26.2 ± 2.4† | 42.9 ± 3.3† | 5.1 ± 0.5 | 25.2 ± 2.4† | 42.5 ± 3.7† |
Normalized for FAV, ml×min−1×100 ml−1 | 0.37 ± 0.06 | 2.34 ± 0.19† | 3.86 ± 0.27† | 0.43 ± 0.05 | 2.26 ± 0.20† | 3.84 ± 0.33† |
Women (n = 15) | ||||||
SaO2, % | 97 ± 0 | 97 ± 0 | 97 ± 0 | 83 ± 1* | 83 ± 1* | 83 ± 1* |
PaO2, Torr | 109 ± 2 | 112 ± 2 | 110 ± 2 | 49 ± 1*‡ | 49 ± 1* | 49 ± 1* |
PvO2, Torr | 39 ± 2 | 25 ± 1† | 27 ± 1 | 30 ± 1* | 23 ± 1*†‡ | 24 ± 1*† |
Arterial O2 content, ml/1 | 160 ± 3‡ | 161 ± 3‡ | 161 ± 3‡ | 135 ± 3*‡ | 138 ± 2*‡ | 140 ± 2*‡ |
Venous O2 content, ml/1 | 108 ± 6‡ | 61 ± 3†‡ | 67 ± 3†‡ | 82 ± 3* | 55 ± 3*†‡ | 54 ± 2*†‡ |
a-v O2, ml/1 | 52 ± 6 | 100 ± 3† | 95 ± 3† | 53 ± 4 | 83 ± 4*† | 86 ± 3*† |
O2 consumption, ml/min | 2.0 ± 0.3‡ | 13.9 ± 1.3†‡ | 21.1 ± 2.1†‡ | 2.4 ± 0.3‡ | 14.0 ± 1.4†‡ | 23.4 ± 2.2*†‡ |
Normalized for FAV, ml×min−1×100 ml−1 | 0.27 ± 0.04 | 1.85 ± 0.17† | 2.82 ± 0.30†‡ | 0.32 ± 0.04 | 1.87 ± 0.20† | 3.13 ± 0.32*† |
Older adults | ||||||
Men (n = 5) | ||||||
SaO2, % | 97 ± 0 | 96 ± 0 | 96 ± 0 | 82 ± 1* | 80 ± 1* | 81 ± 1* |
PaO2, Torr | 101 ± 2 | 96 ± 1 | 97 ± 3 | 45 ± 1* | 43 ± 1* | 46 ± 1* |
PvO2, Torr | 38 ± 2 | 26 ± 2† | 25 ± 1† | 31 ± 2* | 23 ± 1*† | 22 ± 1*† |
Arterial O2 content, ml/1 | 182 ± 5 | 191 ± 6 | 191 ± 5 | 153 ± 5* | 154 ± 6* | 161 ± 4* |
Venous O2 content, ml/1 | 140 ± 13 | 89 ± 10† | 80 ± 8† | 115 ± 5* | 73 ± 8*† | 70 ± 5† |
a-v O2, ml/1 | 51 ± 4 | 102 ± 9† | 110 ± 7† | 38 ± 6* | 81 ± 5*† | 91 ± 3*† |
O2 consumption, ml/min | 4.0 ± 0.4 | 26.4 ± 3.6† | 46.5 ± 6.3† | 3.2 ± 0.4 | 25.5 ± 3.3† | 42.1 ± 5.7† |
Normalized for FAV, ml×min−1×100 ml−1 | 0.40 ± 0.05 | 2.69 ± 0.53† | 4.69 ± 0.83† | 0.32 ± 0.19 | 2.59 ± 0.51† | 4.21 ± 0.67† |
Women (n = 6) | ||||||
SaO2, % | 97 ± 0 | 96 ± 0 | 96 ± 0 | 81 ± 1* | 80 ± 1* | 80 ± 1* |
PaO2, Torr | 99 ± 3 | 98 ± 3 | 96 ± 3 | 47 ± 1* | 46 ± 1*‡ | 46 ± 2* |
PvO2, Torr | 36 ± 3 | 24 ± 2† | 28 ± 4 | 31 ± 2*‡ | 22 ± 1*† | 24 ± 1*† |
Arterial O2 content, ml/1 | 161 ± 7‡ | 164 ± 8‡ | 168 ± 8‡ | 136 ± 7*‡ | 138 ± 5*‡ | 140 ± 7*‡ |
Venous O2 content, ml/1 | 108 ± 10 | 65 ± 7† | 77 ± 18† | 95 ± 14*‡ | 59 ± 1† | 59 ± 7*† |
a-v O2, ml/1 | 53 ± 10 | 99 ± 6† | 91 ± 11† | 41 ± 9*‡ | 80 ± 6*† | 81 ± 5† |
O2 consumption, ml/min | 2.9 ± 0.6 | 16.5 ± 1.5†‡ | 23.1 ± 4.0†‡ | 2.3 ± 0.5 | 15.4 ± 1.5†‡ | 22.0 ± 2.0†‡ |
Normalized for FAV, ml×min−1×100 ml−1 | 0.43 ± 0.10 | 2.42 ± 0.25† | 3.37 ± 0.58† | 0.33 ± 0.19 | 2.24 ± 0.22† | 3.18 ± 0.28† |
Values are means ± SE; n, no. of subjects. SaO2, arterial O2 saturation; PaO2, arterial Po2; PvO2, venous Po2; a-v, arterial-venous.
P < 0.05 vs. normoxia.
P < 0.05 vs. rest.
P < 0.05 vs. men.